Clinical Trial Detail

NCT ID NCT02953782
Title Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications

pancreatic cancer

colorectal cancer

ovarian cancer

Advanced Solid Tumor

breast cancer

head and neck cancer

Therapies

Cetuximab + Hu5F9-G4

Age Groups: senior adult

No variant requirements are available.